Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03646877Phase 1Completed
Phase 1, randomised trial (2 arms). Primary endpoints: Change in Ozone Induced Efferocytosis of Lung Macrophages at 21 days and Change in Ozone Induced Phagocytosis of Lung Macrophages at 21 days. Started Mar 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03646877.